Sponsorship, authorship and accountability

• Revision of statement on publication ethics by the International

---

• 1.
• Henderson L. More AMCs finding growth from reform.Centerwatch 2000; 7(6): 1, 10-13.
• 2.
• Kowalczyk L. Harvard, other medical schools aim to give drug firmsfaster pace for trials. Boston Globe 2000; Jul 28, C4.
• 3.
• Mathieu MP. Parexel's pharmaceutical R&D statisticalsourcebook, 1998 edition. Waltham, Mass: Parexel InternationalCorporation, 1999.
• 4.
• Rennie D. Thyroid storm. JAMA 1997; 277: 1238-1243.
• 5.
• Kahn JO, Cherng DW, Mayer K, et al, for the 806 Investigator Team.Evaluation of HIV-1 immunogen, an immunologic modifier,administered to patients infected with HIV having 300 to 549 x10⁶/LCD4 cell counts. A randomized controlled trial. JAMA 2000;284: 2193-2202.
• 6.
• Blumenthal D, Campbell EG, Anderson MS, et al. Withholdingresearch results in academic life science: evidence from a nationalsurvey of faculty. JAMA 1997; 277: 1224-1228.